Spinocerebellar ataxia type 1 (
SCA1) is one of several
neurodegenerative disorders caused by an expansion of a
polyglutamine tract. It is characterized by
ataxia, progressive motor deterioration, and loss of cerebellar Purkinje cells. To understand the pathogenesis of
SCA1, we examined the subcellular localization of wild-type human
ataxin-1 (the
protein encoded by the
SCA1 gene) and mutant
ataxin-1 in the Purkinje cells of transgenic mice. We found that
ataxin-1 localizes to the nuclei of cerebellar Purkinje cells. Normal
ataxin-1 localizes to several nuclear structures approximately 0.5 microm across, whereas the expanded
ataxin-1 localizes to a single approximately 2-microm structure, before the onset of
ataxia. Mutant
ataxin-1 localizes to a single nuclear structure in affected neurons of
SCA1 patients. Similarly, COS-1 cells transfected with wild-type or mutant
ataxin-1 show a similar pattern of nuclear localization; with expanded
ataxin-1 occurring in larger structures that are fewer in number than those of normal
ataxin-1. Colocalization studies show that mutant
ataxin-1 causes a specific redistribution of the nuclear matrix-associated domain containing promyelocytic leukaemia
protein. Nuclear matrix preparations demonstrate that
ataxin-1 associates with the nuclear matrix in Purkinje and COS cells. We therefore propose that a critical aspect of
SCA1 pathogenesis involves the disruption of a nuclear matrix-associated domain.